NEW YORK, NY / ACCESSWIRE / January 15, 2025 / Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered ...

NEW YORK CITY, NY / ACCESSWIRE / January 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between ...

Fintel reports that on January 13, 2025, William Blair downgraded their outlook for Enfusion (NYSE:ENFN) from Outperform to ...

Enfusion Inc (ENFN) stock saw a modest uptick, ending the day at $10.96 which represents a slight increase of $0.04 or 0.37% from the prior close of $10.92. The stock opened at $10.95 and touched a ...

Morgan Stanley has recently resumed Enfusion Inc (ENFN) stock to Overweight rating, as announced on May 10, 2024, according to Finviz. Earlier, on February 28, 2024, Goldman had reduced the stock from ...

Enfusion (NYSE:ENFN – Get Free Report)‘s stock had its “market perform” rating reaffirmed by equities research analysts at ...

Clearwater Analytics to acquire Enfusion for $1.5 billion in a cash and stock deal, expanding into hedge fund industry with ...

ENFN) Click to Take Action Enfusion, Inc. has entered into a definitive agreement with Clearwater Analytics. The purchase price is $11.25 per share, delivered in an approximately equal mix of cash ...

ENFN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Enfusion, Inc. Is Fair to Shareholders ...

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are ...

Intra-Cellular Therapies, Inc. (Nasdaq: ITCI ) , relating to the proposed merger with Johnson & Johnson. Under the terms of the agreement, Johnson & Johnson will acquire all outstanding shares of ...